Double-blind test of metronidazole and tinidazole in the treatment of asymptomatic Entamoeba histolytica and Entamoeba hartmanni carriers

Am J Trop Med Hyg. 1976 Jul;25(4):549-51. doi: 10.4269/ajtmh.1976.25.549.

Abstract

One hundred and fifteen persons with asymptomatic Entamoeba histolytica or E. hartmanni infection, or both, were given metronidazole (750 mg three times daily for 5 days), tinidazole (1 g twice daily on 2 consecutive days), or a starch placebo. Three post-treatment stools were examined in the 2 weeks following initiation of treatment. Cysts of E. histolytica reappeared in the stools of 37% of 30 given metronidazole, 62% of 34 given tinidazole, and 70% of 31 given placebo. Cysts of E. hartmanni reappeared in the stools of 46% of 24 given metronidazole, 69% of 16 given tinidazole, and 90% of 10 given placebo. Rapid absorption and short duration of treatment make both drugs ineffective for the treatment of ameba carriers.

Publication types

  • Clinical Trial
  • Controlled Clinical Trial
  • Research Support, U.S. Gov't, P.H.S.

MeSH terms

  • Adolescent
  • Adult
  • Aged
  • Amebiasis / drug therapy*
  • Carrier State / drug therapy*
  • Child
  • Clinical Trials as Topic
  • Entamoeba
  • Entamoeba histolytica
  • Entamoebiasis / drug therapy*
  • Entamoebiasis / parasitology
  • Feces / parasitology
  • Humans
  • Metronidazole / adverse effects
  • Metronidazole / therapeutic use*
  • Middle Aged
  • Nitroimidazoles / therapeutic use*
  • Tinidazole / adverse effects
  • Tinidazole / therapeutic use*

Substances

  • Nitroimidazoles
  • Tinidazole
  • Metronidazole